If you decide to go with Lu 177 PSMA treatment you will need a PSMA PET/CT but it will be advisable to get a 18 F FDG PET/CT..
If it is impossible to get a 18 F FDG PET/CT request the SUV values of the metastases and the liver. If there are no metastases with SUV values similar or greater than the SUV of the liver or if there is diffuse infiltration of the bone marrow in the PSMA PET/CT, Lu 177 PSMA treatment may not be a good choice of treatment.
Consider requesting a direct biopsy of the mets to do histological, IHC and genetic studies of the cancer to see if the cancer may be susceptible to treatment with specific drugs or with chemo plus platinum compounds.
Lu 177 PSMA treatment treats the cancer everywhere and it is effective for treating bone metastases.
If there is diffuse infiltration of the bone marrow by the cancer, Lu 177 PSMA may not be a good choice because the cancer cells are in proximity to the bone marrow cells .
The radiation of the Lu 177 PSMA (beta radiation which could travel 3 mm) will affect the bone marrow cells close to the cancer cells and it may cause bone marrow failure.
When there is diffuse bone marrow infiltration by the cancer some centers in Germany treat these patients with Ac 225 PSMA initially and then a mixture of Ac 225 and Lu 177 PSMA. Ac 225 emits alpha radiation which does not travel more than the diameter of a few cells causing less damage to the bone marrow cells.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.